Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-007625

Options or other derivatives

  • Senior Vice President and CFO acquired 18,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-21 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +18,000 18,000 D
Loading xslF345X03/form4.xml…